Skip to main content
Elizabeth Berry-Kravis, MD, Child Neurology, Chicago, IL

Elizabeth Berry-Kravis MD


Professor, Pediatrics, Rush Medical College of Rush Univ

Join to View Full Profile
  • 1725 W Harrison StSte 710Chicago, IL 60612

  • Phone+1 312-942-3034

Dr. Berry-Kravis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Chicago
    University of ChicagoResidency, Neurology, 1987 - 1990
  • University of Chicago
    University of ChicagoResidency, Pediatrics, 1985 - 1987
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1987 - 2029
  • Neurology with Special Qualification in Child Neurology
    American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
  • Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
  • Long-Term Treatment of Niemann-Pick Type C1 Disease with Intrathecal 2-Hydroxypropyl-Β-cyclodextrinJanuary 2018

Press Mentions

  • FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C
    FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type CDecember 9th, 2025
  • Chicago Doctor Dedicated to Changing Lives of Kids with Rare Neurological Diseases
    Chicago Doctor Dedicated to Changing Lives of Kids with Rare Neurological DiseasesDecember 6th, 2025
  • MVX-220 Angelman Gene Therapy Trial Enters First Human Testing
    MVX-220 Angelman Gene Therapy Trial Enters First Human TestingDecember 1st, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: